Progyny Tops Q2 Estimates, Lifts Full-Year Forecast, and Presses Buyback

summarizeSummary

Progyny posted better-than-expected Q2 2026 results—revenue of $350.5M and net income of $28.1M—and raised its full-year guidance while continuing to repurchase shares, buying back 1.2M in the quarter.

check_boxKey Events · Earnings and Guidance · PGNY

• Q2 Revenue and Earnings Beat

  Revenue reached $350.5M, up 5.3% year over year, and net income came in at $28.1M, or $0.34 per diluted share, exceeding expectations on the back of client growth and higher utilization.

• Margin Expansion

  Gross margin expanded 180 basis points to 25.5%, while the Adjusted EBITDA margin improved to 17.7%, reflecting operating efficiencies and lower stock-based compensation.

• Raised Full-Year Guidance

  Full-year 2026 revenue guidance was raised to $1.360B–$1.385B, implying 5.5%–7.5% growth, with net income projected at $104.8M–$109.9M and Adjusted EBITDA at $233M–$240M.

• Share Buyback Continues

  Under the May 2026 $200M program, 1.2M shares were repurchased for $31.5M in Q2, leaving $142.5M authorized; cumulative buybacks across all programs now total 10.8M shares.

auto_awesomeAnalysis · PGNY · Industrial Applications And Services

A strong second quarter saw revenue climb 5.3% to $350.5M while net income surged 64% to $28.1M. Gross margin widened 180 basis points to 25.5%, and Adjusted EBITDA advanced 7.2% to $62.1M. Management raised its full-year revenue and profit outlook, underscoring confidence in the selling season and client retention. The buyback added a return-of-capital tailwind, with 1.2M shares repurchased during the quarter. Whether the stock responds further will depend on how much of the beat was already discounted.